Southern Acids (M) Bhd (5134) - Net Assets
Based on the latest financial reports, Southern Acids (M) Bhd (5134) has net assets worth RM868.60 Million MYR (≈ $218.08 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM992.30 Million ≈ $249.14 Million USD) and total liabilities (RM123.71 Million ≈ $31.06 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Southern Acids (M) Bhd (5134) total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM868.60 Million |
| % of Total Assets | 87.53% |
| Annual Growth Rate | 4.09% |
| 5-Year Change | 22.28% |
| 10-Year Change | 39.74% |
| Growth Volatility | 3.79 |
Southern Acids (M) Bhd - Net Assets Trend (2013–2025)
This chart illustrates how Southern Acids (M) Bhd's net assets have evolved over time, based on quarterly financial data. Check Southern Acids (M) Bhd (5134) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Southern Acids (M) Bhd (2013–2025)
The table below shows the annual net assets of Southern Acids (M) Bhd from 2013 to 2025. For live valuation and market cap data, see 5134 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | RM779.74 Million ≈ $195.77 Million |
+0.02% |
| 2024-03-31 | RM779.57 Million ≈ $195.72 Million |
+3.26% |
| 2023-03-31 | RM754.93 Million ≈ $189.54 Million |
+3.77% |
| 2022-03-31 | RM727.47 Million ≈ $182.64 Million |
+14.08% |
| 2021-03-31 | RM637.66 Million ≈ $160.10 Million |
+7.27% |
| 2020-03-31 | RM594.42 Million ≈ $149.24 Million |
-1.14% |
| 2019-03-31 | RM601.28 Million ≈ $150.96 Million |
+2.54% |
| 2018-03-31 | RM586.38 Million ≈ $147.22 Million |
+3.10% |
| 2017-03-31 | RM568.76 Million ≈ $142.80 Million |
+1.93% |
| 2016-03-31 | RM558.00 Million ≈ $140.10 Million |
+3.53% |
| 2015-03-31 | RM539.00 Million ≈ $135.33 Million |
+4.46% |
| 2014-03-31 | RM516.00 Million ≈ $129.55 Million |
+7.05% |
| 2013-03-31 | RM482.00 Million ≈ $121.01 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Southern Acids (M) Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 66.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM630.29 Million | 80.83% |
| Common Stock | RM171.25 Million | 21.96% |
| Total Equity | RM779.74 Million | 100.00% |
Southern Acids (M) Bhd Competitors by Market Cap
The table below lists competitors of Southern Acids (M) Bhd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tunghsu Azure Renewable Energy Co Ltd
SHE:000040
|
$106.61 Million |
|
Woongjin Co Ltd
KO:016880
|
$106.65 Million |
|
Shin Foong Specialty and Applied Materials Co
TW:6582
|
$106.71 Million |
|
Seah Spe Steel
KO:019440
|
$106.71 Million |
|
Han Chang Pape
KO:009460
|
$106.55 Million |
|
Duro Felguera
MC:MDF
|
$106.55 Million |
|
CVC Income & Growth Limited
LSE:CVCE
|
$106.54 Million |
|
Minaurum Silver Inc.
V:MGG
|
$106.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Southern Acids (M) Bhd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 779,570,000 to 779,743,000, a change of 173,000 (0.0%).
- Net income of 36,702,000 contributed positively to equity growth.
- Dividend payments of 6,847,000 reduced retained earnings.
- Other factors decreased equity by 29,682,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM36.70 Million | +4.71% |
| Dividends Paid | RM6.85 Million | -0.88% |
| Other Changes | RM-29.68 Million | -3.81% |
| Total Change | RM- | 0.02% |
Book Value vs Market Value Analysis
This analysis compares Southern Acids (M) Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.54x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.75x to 0.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | RM4.15 | RM3.10 | x |
| 2018-03-31 | RM4.28 | RM3.10 | x |
| 2019-03-31 | RM4.39 | RM3.10 | x |
| 2020-03-31 | RM4.34 | RM3.10 | x |
| 2021-03-31 | RM4.66 | RM3.10 | x |
| 2022-03-31 | RM5.31 | RM3.10 | x |
| 2023-03-31 | RM5.51 | RM3.10 | x |
| 2024-03-31 | RM5.69 | RM3.10 | x |
| 2025-03-31 | RM5.69 | RM3.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Southern Acids (M) Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.71%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.37%
- • Asset Turnover: 1.08x
- • Equity Multiplier: 1.29x
- Recent ROE (4.71%) is below the historical average (5.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 8.57% | 6.58% | 1.05x | 1.24x | RM-8.15 Million |
| 2018 | 5.55% | 4.27% | 1.06x | 1.22x | RM-26.08 Million |
| 2019 | 3.57% | 3.59% | 0.82x | 1.22x | RM-38.64 Million |
| 2020 | 5.38% | 4.85% | 0.91x | 1.22x | RM-27.44 Million |
| 2021 | 5.86% | 5.04% | 0.91x | 1.27x | RM-26.41 Million |
| 2022 | 12.98% | 8.03% | 1.21x | 1.33x | RM21.67 Million |
| 2023 | 4.41% | 3.03% | 1.13x | 1.29x | RM-42.20 Million |
| 2024 | 1.75% | 1.50% | 0.89x | 1.31x | RM-64.32 Million |
| 2025 | 4.71% | 3.37% | 1.08x | 1.29x | RM-41.27 Million |
Industry Comparison
This section compares Southern Acids (M) Bhd's net assets metrics with peer companies in the Conglomerates industry.
Industry Context
- Industry: Conglomerates
- Average net assets among peers: $2,753,305,719
- Average return on equity (ROE) among peers: -6.89%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Southern Acids (M) Bhd (5134) | RM868.60 Million | 8.57% | 0.14x | $106.58 Million |
| Digistar Corporation Bhd (0029) | $51.32 Million | -32.65% | 6.55x | $6.30 Million |
| Key Alliance Group Bhd (0036) | $127.76 Million | -37.66% | 0.35x | $2.31 Million |
| MSCM Holdings Bhd (0041) | $63.68 Million | -13.57% | 0.57x | $14.11 Million |
| Asdion Bhd (0068) | $11.26 Million | -35.97% | 2.52x | $641.09K |
| EA Holdings Bhd (0154) | $88.26 Million | 5.21% | 0.07x | $8.10 Million |
| Sports Toto Berhad (1562) | $737.83 Million | 17.98% | 2.94x | $453.22 Million |
| Batu Kawan Bhd (1899) | $8.66 Billion | 5.59% | 0.51x | $2.08 Billion |
| Kuala Lumpur Kepong Bhd (2445) | $6.33 Billion | 16.00% | 0.45x | $6.03 Billion |
| Hap Seng Consolidated Bhd (3034) | $9.27 Billion | 8.63% | 1.01x | $1.70 Billion |
| Berjaya Assets Bhd (3239) | $2.19 Billion | -2.47% | 0.58x | $192.69 Million |
About Southern Acids (M) Bhd
Southern Acids (M) Berhad, an investment holding company, engages in the manufacture and trading of oleochemical products in Malaysia, Indonesia, Asia, Europe, the United States, and internationally. The company operates through four segments: Oleochemical Manufacturing, Milling & Cultivation, Investments & Services, and Healthcare Services. It offers fatty acids and glycerine for use in various … Read more